Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Doxil and Carboplatin, Plus Herceptin in HER2+ Patients, in Metastatic Breast Cancer

NCT00303108 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT00303108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00303108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Doxil and Carboplatin, Plus Herceptin in HER2+ Patients, in Metastatic Breast Cancer
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
June 30, 2011
Enrollment
136 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer